Format

Send to

Choose Destination
See comment in PubMed Commons below
Obstet Gynecol. 2008 Jun;111(6):1268-73. doi: 10.1097/AOG.0b013e31816de8ad.

Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial.

Author information

1
Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center, San Jose, California 95128, USA. neene.duggal@hhs.sccgov.org

Abstract

OBJECTIVE:

To estimate whether prophylactic antibiotics at the time of repair of third- or fourth-degree perineal tears after vaginal delivery prevent wound infection and breakdown.

METHODS:

This was a prospective, randomized, placebo-controlled study. Patients who sustained third- or fourth-degree perineal tears after a vaginal delivery were recruited for the study. Each patient was given a single intravenous dose of a second-generation cephalosporin (cefotetan or cefoxitin) or placebo before repair of third- or fourth-degree perineal tears. Obstetricians and patients were blinded to study drug. The perineum was inspected for evidence of infection or breakdown at discharge from the hospital and at 2 weeks postpartum. Primary end points were gross disruption or purulent discharge at site of perineal repair by 2 weeks postpartum.

RESULTS:

One hundred forty-seven patients were recruited for the study. Of these, 83 patients received placebo and 64 patients received antibiotics. Forty patients (27.2%) did not return for their 2-week appointment. Of the patients seen at 2 weeks postpartum, 4 of 49 (8.2%) patients who received antibiotics and 14 of 58 (24.1%) patients who received placebo developed a perineal wound complication (P=.037). There were no differences between groups in parity, incidence of diabetes, operative delivery, or third-degree compared with fourth-degree lacerations.

CONCLUSION:

By 2 weeks postpartum, patients who received prophylactic antibiotics at the time of third- or fourth-degree laceration repair had a lower rate of perineal wound complications than patients who received placebo.

CLINICAL TRIAL REGISTRATION:

ClinicalTrials.gov, www.clincaltrials.gov, NCT00186082.

LEVEL OF EVIDENCE:

I.

Comment in

PMID:
18515507
DOI:
10.1097/AOG.0b013e31816de8ad
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center